Polymers are emerging as powerful alternatives to viral vectors for DNA delivery, enabling safer and more flexible approaches for DNA vaccines and in vivo CAR-T therapies.
Read moreJosep Samitier: “It’s key to strengthen public-private collaboration and attract venture capital to promote emerging projects that will allow us to consolidate technological and productive capacit...
Read moreLa Agencia Estadounidense de Alimentos y Medicamentosha aprobado el medicamento de terapia génica denominado KRESLADI™ (marnetegragene autotemcel) de la empresa Rocket Pharma para el tratamiento de...
Read moreCurapath has partnered with Nacalai Tesque to expand access to its portfolio of next-generation polymers and PEG-free shielding lipids for advanced drug delivery applications in Japan.
Read morePartnership during the last 8 years leverages VIVEbiotech’s decade of experience manufacturing GMP ex- and in- vivo lentiviral vectors for the advanced therapies sector
Read moreTransfection-free stable producer cell line (SCL) offers easy scalability, reduction of cost of goods (COGs), improve vector quality, and low batch variability.
Read moreEl escenario regulatorio de las Terapias Avanzadas es complejo. En él conviven autorizaciones de uso hospitalario con medicamentos plenamente aprobados por la EMA. Entender esta dualidad permite anti...
Read moreCientíficos, empresas de biotecnología y farmacéuticas, fondos de inversión y asociaciones de pacientes se han reunido en Pamplona para debatir los nuevos desafíos en el tratamiento de enfermedad...
Read moreNow advancing 15 next-generation in vivo therapies through high-performance, scalable lentiviral vector manufacturing capabilities
Read moreA research team from the Universitat Autònoma de Barcelona (UAB) has shown that a one-time administration of a gene therapy expressing the metabolic factor FGF21 can prolong health span in old mice....
Read moreOver the course of one week, it will host in-person assessments for 35 families to better understand the progression of the disease and contribute to the development of new therapies.
Read moreIt is the first centre in Spain to achieve this accreditation, which places its operations on a par with those of a pharmaceutical laboratory and consolidates the leadership of the Advanced Therapies ...
Read more